Abstract
B LYMPHOCYTES are key participants in the immune response because of their specificity, their ability to take up and present antigens to T cells, and their capacity to differentiate into antibody-secreting cells. To limit reactivity to self antigens, autospecific B cells can be functionally inactivated or deleted1–4. Developing B cells that react with membrane antigens expressed in the bone marrow are deleted from the peripheral lymphocyte pool4–6. It is important to ascertain the fate of B cells that recognize membrane autoantigens expressed exclusively on peripheral tisues because B cells in the peripheral lymphoid organs are phenotypically and functionally distinct from bone-marrow B cells7–9. Here we show that in immunoglobulin-transgenic mice, B cells specific for major histocompatibility complex class I antigen can be deleted if they encounter membrane-bound antigen at a post-bone-marrow stage of development. This deletion may be necessary to prevent organ-specific autoimmunity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nossal, G. J. V. Science 24, 147–153 (1989).
Goodnow, C. C. et al. Nature 334, 676–682 (1988).
Erikson, J. et al. Nature 349, 331–334 (1991).
Nemazee, D. & Bürki, K. Nature 337, 562–566 (1989).
Nemazee, D. & Bürki, K. Proc natn. Acad Sci. U.S.A. 86, 8039–8043 (1989).
Nemazee, D. et al. Immunol. Rev. 122, 117–132 (1991).
Raff, M. C. et al. J. exp. Med. 142, 1052–1064 (1975).
Sidman, C. L. & Unanue, E. R. Nature 257, 149–151 (1975).
Gu, H., Tarlington, D., Müller, W., Rajewsky, K. & Förster, I. J. exp. Med. 173, 1357–1371 (1991).
Morahan, G. et al. Proc. natn. Acad. Sci. U.S.A. 86, 3782–3786 (1989).
Vitetta, E. S., Cambier, J. C., Ligler, F. S., Kettman, J. R. & Uhr, J. W. J. exp. Med. 146, 1804–1810 (1977).
Scott, D. W., Layton, J. E. & Nossal, G. V. J. J. exp. Med. 146, 1473–1483 (1977).
Tisch, R., Roifman, C. M. & Hozumi, N. Proc. natn. Acad. Sci. U.S.A. 85, 6914–6918 (1988).
Alés-Martínez, J. E., Warner, G. L. & Scott, D. W. Proc. Natn. Acad. Sci. U.S.A. 85, 6919–6923 (1988).
Rammensee, H.-G., Bevan, M. J. & Fink, P. J. Immun. Today 6, 41–43 (1985).
Chestnut, R. W. & Grey, H. M. J. Immun. 115, 1075–1079 (1981).
Ron, Y. & Sprent, J. J. immun. 128, 2848–2856 (1987).
Nakamura, R. M., Voller, A. & Bidwell, D. E. in Handbook of Experimental Immunology 4th edn (eds Weir, D. M., Herzenberg, I. A., Blackwell, C. C. & Herzenberg, L. A.) 26.1–27.20 (Blackwell, London, 1986).
Leptin, M. et al. Eur. J. Immun. 13, 534–542 (1984).
Nemazee, D. A. in Proc. EMBO Workshop on Tolerance (eds Matzinger, P. et al.) Vol. 2 52–54 (Editiones Roche, Basel, 1987).
Coffman, R. L. & Weissman, I. L. Nature 289, 681–683 (1981).
Ozato, K., Mayer, N. & Sachs, D. H. J. Immun. 124, 533–540 (1980).
Dembiċ, Z. et al. Nature 320, 232–238 (1986).
Grosveld, F. G. et al. Nucleic Acids Res. 10, 67145–6732? (1982).
Sieckman, D. Fed. Proc. 43, 488 (1987).
Stall, A. M. & Loken, M. R. J. Immun. 132, 787–795 (1984).
Hardy, R. R. in Handbook of Experimental Immunology 4th edn (eds Weir, D. M., Herzenberg, L. A., Blackwell, C. C. & Herzenberg, L. A.) 97.1–97.17 (Blackwell, London, 1986).
Steinmetz, M. et al. Cell 25, 125–134 (1981).
Jones, D. T. & Reed, R. R. J. biol. Chem. 262, 13241–14249 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Russell, D., Dembić, Z., Morahan, G. et al. Peripheral deletion of self-reactive B cells. Nature 354, 308–311 (1991). https://doi.org/10.1038/354308a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/354308a0
This article is cited by
-
In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice
Nature Biotechnology (2022)
-
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Nature Communications (2020)
-
The Immunogenicity of Antibody Aggregates in a Novel Transgenic Mouse Model
Pharmaceutical Research (2015)
-
B-lymphocyte tolerance and effector function in immunity and autoimmunity
Immunologic Research (2013)
-
Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity
Leukemia (2011)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.